For the Inventor, By the Inventor

Enter assignee name

Bratislava, Slovakia

Institute of Virology of the Slovak Academy of Sciences

USPTO Granted Patents = 18

Forward Citations = 44

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Jaromir Pastorek (14 out of 36 patents)

Silvia Pastorekova (14 out of 36 patents)

Jan Zavada (7 out of 26 patents)

4. Claudiu Supuran (6 out of 13 patents)

5. Andrea Scozzafava (6 out of 8 patents)

6. Miriam Zatovicova (3 out of 3 patents)

7. Marta Ortova Gut (3 out of 3 patents)

8. Zuzanna Zavadova (3 out of 3 patents)

9. Peter John Ratcliffe (2 out of 15 patents)

10. Adrian Llewllyn Harris (2 out of 10 patents)

11. Christoph Röcken (1 out of 3 patents)

12. Matthias Ebert (1 out of 3 patents)

13. Bülent Soyupak (1 out of 2 patents)

14. Seyda Erdogan (1 out of 2 patents)

15. Thambi Dorai (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 8025865 - CA IX-specific inhibitors (2011-09-27),

2. 8012707 - MN gene and protein (2011-09-06),

3. 7993852 - MN/CA IX and cancer prognosis (2011-08-09),

4. 7910691 - MN gene and protein (2011-03-22),

5. 7910549 - MN gene and protein (2011-03-22),

6. 7855185 - MN gene and protein (2010-12-21),

7. 7846673 - Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX'S coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes (2010-12-07),

8. 7838240 - MN/CA IX/CA9 and renal cancer prognosis (2010-11-23),

9. 7833739 - CA IX-specific inhibitors (2010-11-16),

10. 7833738 - CA IX-specific inhibitors (2010-11-16),

11. 7833737 - CA IX-specific inhibitors (2010-11-16),

12. 7833734 - CA IX-specific inhibitors (2010-11-16),

13. 7833728 - Soluble form of carbonic anhydrase IX (s-CA IX), assays to detect s-CA IX, CA IX's coexpression with HER-2/neu/c-erbB-2, and CA IX-specific monoclonal antibodies to non-immunodominant epitopes (2010-11-16),

14. 7833514 - CA IX-specific inhibitors (2010-11-16),

15. 7829065 - CA IX-specific inhibitors (2010-11-09),

The Institute of Virology of the Slovak Academy of Sciences (UVSA) is a leading scientific institution in Slovakia dedicated to the study of viruses and viral diseases. With a rich history spanning several decades, UVSA conducts research, education, and collaboration to advance virology knowledge. Its team of expert virologists works on various aspects of virus-host interactions, viral pathogenesis, diagnostics, and antiviral therapies. UVSA is committed to providing innovative solutions in virology, contributing to public health, and fostering international scientific cooperation.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

18 Patents

#2 in Bratislava

#2 in Slovakia

#33,129 in the World

Bratislava, Slovakia

Institute of Virology of the Slovak Academy of Sciences

Forward Citations = 44

15 inventors:

Jaromir Pastorek (14 out of 36 patents)

Silvia Pastorekova (14 out of 36 patents)

Jan Zavada (7 out of 26 patents)

4. Claudiu Supuran (6 out of 13 patents)

5. Andrea Scozzafava (6 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…